Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EPS Growth

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year EPS Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EPS Growth(%) 169.73-605.16-68.44-2.9225.01

What is the latest EPS Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EPS Growth ratio of GLENMARK PHARMACEUTICALS is 169.73 based on Mar2025 Consolidated results.
Year EPS Growth
Mar2025169.73
Mar2024-605.16
Mar2023-68.44
Mar2022-2.92
Mar202125.01

How is EPS Growth of GLENMARK PHARMACEUTICALS Trending?

Years EPS Growth % Change
Mar2025 169.73
Positive
Mar2024 -605.16
Negative
Mar2023 -68.44
Negative
Mar2022 -2.92
Negative
Mar2021 25.01 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EPS Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,045.5 Cr -3.9% -5.4% 38.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr 1.2% -5.3% -5.6% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -3.9% -6% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr 0.9% 3.7% 20.5% Stock Analytics
CIPLA ₹105,961.0 Cr -1.2% -12.6% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -3.4% -5.7% 0.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.9%

-5.4%

38.5%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses